Gruma (GRUMA) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
28 Jul, 2026Executive summary
Global leader in corn flour and tortilla production with strong brand awareness and leading market positions across the Americas, Europe, Asia, and Oceania.
Net sales grew 3% year-over-year to $1.65 billion, driven by strong performance in Europe, Asia, Oceania, and Central America, offsetting U.S. softness.
U.S. subsidiary faced continued volume contraction, mainly in the food service channel, due to price sensitivity and weak consumer sentiment.
Focuses on health-oriented innovation and value-added, higher-margin products to drive growth.
Majority net income fell 12% to $118.7 million, reflecting lower operating income and increased financing costs.
Financial highlights
Consolidated sales rose 3% year-over-year, supported by growth in Europe, Asia, Oceania, and Central America.
EBITDA contracted 5% year-over-year to $276.5 million, with margin contracting 130 basis points to 16.8% due to higher costs.
Net Debt/EBITDA increased to 1.5x due to seasonal inventory buildup in Mexico.
U.S. operation: volumes and sales contracted 3%, EBITDA down 15% year-over-year.
Europe: sales up 5%, EBITDA up 17% year-over-year, margin at 14.8%.
Central America: volumes up 3%, sales up 7%, EBITDA up 12%, margin at 19%.
Asia & Oceania: volumes up 4%, sales up 15%, EBITDA up 47%, margin at 16.2%.
Outlook and guidance
Guidance revised: low single-digit volume and revenue decline for U.S. subsidiary, with EBITDA margin down 200 basis points.
Consolidated guidance: fractional decline in revenue and volume, EBITDA margin contraction of ~160 basis points.
Management expects a meaningful recovery in U.S. operations once consumer confidence rebounds, with continued strong contributions from other regions.
Third quarter expected to be a transition period for U.S. food service stabilization.
Expects continued margin improvement through a shift to higher-margin SKUs, healthier alternatives, and operational efficiencies.
Latest events from Gruma
- Net sales rose 5% to US $6.5B, with EBITDA growth led by international and health-focused products.GRUMA
Q1 2026 - Margins compressed as costs rose, but innovation and global demand supported profitability.GRUMA
Q4 2025 - EBITDA and sales grew as international gains offset U.S. headwinds.GRUMA
Q3 2025 - EBITDA and margins rose as global growth and innovation offset U.S. softness.GRUMA
Q2 2025 - EBITDA rose 3% as innovation and international growth offset lower sales and U.S. food service declines.GRUMA
Q3 2024 - EBITDA up 17% and net income 42% as margin expansion offset flat sales and logistics issues.GRUMA
Q2 2024 - EBITDA and net income rose despite lower sales, driven by innovation and global diversification.GRUMA
Q1 2025 - EBITDA and net income rose in Q4 2024, with strong cash flow and lower debt.GRUMA
Q4 2024